This Data Signals The End For Merck's Anacetrapib By: Benzinga via Benzinga April 04, 2016 at 11:33 AM EDT The ACCELERATE study data for Evacetrapib, which is a selective inhibitor of cholesteryl ester transfer protein [CETP] of Eli Lilly ... Read More >> Related Stocks: Amgen Eli Lilly Merck & Co